Hormone replacement therapy: your pre-consultation checklist
An HRT appointment has to do several jobs at once: establish what is happening, review your health history, weigh benefits and risks, and decide whether treatment makes sense.
That can be a lot to fit into one visit, especially if symptoms are difficult to describe or your medical history is spread across old records and recent prescriptions.
A little preparation helps the conversation stay specific. You do not need to arrive with a diagnosis or a preferred prescription. You do need a clear account of what has changed, what matters most to you, and what the clinician should know before discussing treatment.
The most useful preparation is clinical context: what you are experiencing, when it began, and which parts of your history could affect the options.
Documenting your symptom timeline and health history
Menopause symptoms rarely arrive as a neat list. Hot flashes may be obvious; changes in sleep, mood, concentration, or sexual comfort can be harder to connect to the menopause transition. A short record in the weeks before your appointment can help you describe the pattern without having to reconstruct it from memory.
There is no required tracking period. Write things down for as long as is practical, even if that is only a few days. The aim is to capture useful detail, not to produce a perfect diary.
For each symptom, note when it occurs, how often, how disruptive it is, and whether anything seems to bring it on or ease it. For example, “waking hot several times a night” gives a clinician more to work with than “sleep is poor.” You might track:
- Hot flashes and night sweats, including their frequency, duration, and effect on sleep or daily activities.
- Sleep changes, such as difficulty falling asleep, waking during the night, or waking earlier than usual.
- Mood or cognitive changes, including irritability, anxiety, low mood, or trouble concentrating.
- Vaginal or urinary symptoms, such as dryness, discomfort with sex, urgency, or recurrent urinary infections.
- Changes in menstrual bleeding, including cycle length, irregularity, unusually heavy bleeding, or spotting.
- Other changes you want to discuss, such as joint discomfort, headaches, or shifts in sexual desire.
Record your last menstrual period if you know it, and note whether bleeding has changed. Bleeding after menopause, generally understood as bleeding after 12 months without a period, needs medical assessment. Tell the clinician about it promptly; do not assume it is simply part of menopause or wait for an HRT review to raise it.
Bring the history that changes the discussion
A focused medical history is more useful than an exhaustive list of every illness you have ever had. Include important diagnoses, operations, and events, with approximate dates where you can. In particular, mention:
| History to share | Why it may matter |
|---|---|
| Breast or endometrial cancer, or another hormone-sensitive cancer | May affect whether systemic hormone therapy is appropriate and calls for individualized advice |
| A previous blood clot, pulmonary embolism, stroke, or coronary heart disease | Helps the clinician assess treatment risks and routes of administration |
| Liver disease | May affect medication choice and how it is processed |
| Migraine, especially migraine with aura | Relevant to the overall risk discussion and choice of formulation |
| Hysterectomy or other relevant surgery | Helps determine whether a progestogen is needed with systemic estrogen |
| Osteoporosis, fragility fracture, or premature ovarian insufficiency | May change the broader treatment and monitoring plan |
| Significant family history of breast or ovarian cancer, blood clots, or early heart disease | Can inform risk assessment, particularly when the relative’s age at diagnosis is known |
If you know the age at which a close relative was diagnosed with cancer or had a blood clot, bring that detail. If you do not know, say so; a best estimate is better than presenting a guess as fact. Family history matters, but it does not by itself determine whether HRT is suitable.
Bring a current medication list, including doses where possible. Include prescribed medicines, over-the-counter products, supplements, hormonal contraception, and any hormone treatment you have used before. Some medicines and supplements can affect hormone levels or interact with treatment. If a written list is inconvenient, photographs of medication packaging can help.
Essential baseline information before your visit
You do not need to complete a battery of tests on your own before asking about HRT. What is useful depends on your age, symptoms, medical history, and local screening guidance. The clinician can tell you whether any examination, test, or record update is needed.
A recent blood pressure reading is useful, particularly if you have hypertension or cardiovascular risk factors. If you measure at home, use a properly fitting cuff, sit quietly for a few minutes first, and record the readings with their dates. Several measurements on different days may give a more representative picture than one isolated result. Do not delay an appointment because you have not collected home readings.
Bring your height and recent weight if you know them. They can contribute to an overall health assessment, but a body mass index is only one part of risk evaluation. There is no single BMI value that automatically determines the appropriate HRT route. A clinician should consider the whole picture, including personal history of clotting, smoking, blood pressure, mobility, other conditions, and your preferences.
It can also help to know whether routine preventive care is up to date. Breast and cervical screening recommendations vary by age, country, and personal history. A recent screening result may be relevant, but screening is not a substitute for evaluating a new symptom. If you have breast symptoms or unexplained bleeding, mention them directly rather than relying on a routine screening appointment to address them.
Blood tests are not always needed to diagnose menopause in someone whose symptoms and menstrual history fit the expected pattern. Testing may be considered in particular circumstances, including younger age, uncertainty about the cause of symptoms, or suspected premature ovarian insufficiency. Ask what a proposed test is intended to clarify. Commercial saliva or finger-prick hormone kits cannot, on their own, establish whether HRT is appropriate or determine a safe dose.
Navigating the safety conversation: estrogen and progestogen protocols
HRT is not one standard prescription. The choice depends on symptoms, health history, whether you have a uterus, and what matters to you. Two points are especially useful to understand before the appointment.
First, someone with a uterus who uses systemic estrogen usually needs a progestogen as well. It protects the lining of the uterus from the effects of estrogen. The appropriate regimen depends on the treatment plan and individual circumstances. If you have had a hysterectomy, ask whether a progestogen is needed and why; it is often not required, although the answer can depend on surgical details and other clinical factors.
Second, estrogen can be taken by different routes. Tablets pass through the liver before reaching the circulation; patches, gels, and sprays are absorbed through the skin. Evidence suggests that transdermal estrogen may have a lower effect on clot risk than oral estrogen. This can make it a consideration for people with certain risk factors, but it does not make every individual risk disappear or make one route right for everyone.
| Consideration | Oral estrogen | Transdermal estrogen |
|---|---|---|
| How it is taken | Tablet by mouth | Patch, gel, or spray applied to the skin |
| Processing | Passes through the liver before reaching the circulation | Enters through the skin, avoiding the same first-pass liver effect |
| Clot-risk discussion | May be less suitable for some people with elevated clot risk | Often considered when clot risk is a concern; individual assessment still matters |
| Practical preferences | May suit someone who prefers a daily tablet | May suit someone who prefers to avoid tablets, though skin application and patch use have their own practical considerations |
| Other clinical factors | Can affect triglycerides and some liver-produced proteins | May have different effects on triglycerides and liver-produced proteins |
A history of venous thromboembolism, smoking, migraine with aura, cardiovascular disease, or other health conditions deserves an individualized conversation. These factors do not all carry the same implications, and a single measurement or label cannot settle the decision. Ask how your own history affects the route, dose, and whether specialist input is advisable.
Progestogen options may include micronized progesterone, other progestogen medicines, or a levonorgestrel-releasing intrauterine device in appropriate circumstances. They differ in how they are taken, their side effects, and how they may affect bleeding. The choice should be explained in terms of your uterus, symptoms, preferences, and medical history. If you have had bothersome side effects from a previous regimen, describe what happened and when.
Strategic questions for a limited appointment
A prepared question list helps, but it should not become another test to pass. Choose the questions that fit your situation and put the most important ones first. For many people, these are a useful starting point:
1. Based on my symptoms and health history, what are the reasonable treatment options, including options other than systemic HRT?
2. If systemic estrogen is appropriate, which route and dose would you consider, and what in my history informs that choice?
3. If I have a uterus, what is the plan for protecting its lining?
4. What benefits should I expect for the symptoms I most want to address, and when should we review whether treatment is helping?
5. What side effects should I watch for, and which symptoms mean I should contact you sooner?
6. What should I do if I have unexpected bleeding while using HRT?
7. What follow-up do you recommend, and what would lead you to change the dose, route, or treatment?
8. Are there interactions with my current medicines, supplements, or contraception?
If your symptoms began at a younger age than expected, or you may have premature ovarian insufficiency, ask how that changes the discussion. You might also ask whether further evaluation is needed and how bone and cardiovascular health should be addressed over time.
Be ready to say what improvement would matter most to you. Better sleep, fewer disruptive hot flashes, relief from vaginal discomfort, or a different goal may lead to different treatment choices. It is also reasonable to discuss concerns about cancer, blood clots, or side effects openly. A useful consultation makes room for uncertainty and explains how the clinician is weighing it.
Setting expectations for follow-up and treatment efficacy
Starting HRT is the beginning of a treatment plan, not the end of the decision. The timing of review varies with the treatment, the person’s health, and local practice. Ask when your clinician wants to hear from you and whether the review will be in person or by another method.
Keep tracking the symptoms that led you to seek care. A brief note about what is improving, what is unchanged, and any side effects gives the follow-up conversation a clear basis. Some symptoms may respond differently from others, and treatment may need adjustment. Do not change the dose or stop a prescribed regimen without discussing the plan with your clinician, unless you have been given specific instructions for an urgent reaction.
Ask what changes should prompt contact before the scheduled review. New or unusual bleeding, a suspected blood clot, chest pain, or new neurological symptoms need prompt medical attention. Your clinician can explain which symptoms apply to your circumstances and how to seek care.
Once a regimen is established, continue to review whether its benefits still matter to you and whether your health history has changed. A new diagnosis, a new medication, or a change in priorities can alter the conversation. Regular review is an opportunity to revisit the dose, route, ongoing need, and any screening or monitoring relevant to your care.
You do not need to arrive knowing which treatment you want. Bring a symptom timeline, a concise medical and medication history, and the questions that matter most. That gives the consultation something more useful than a rushed decision: a shared starting point for choosing, reviewing, and adjusting care.